Literature DB >> 23141208

Re-emergence of posttraumatic stress disorder nightmares with nursing home admission: treatment with prazosin.

Kim G Johnson1, Jules Rosen.   

Abstract

Seniors with a history of emotional trauma decades earlier can experience a recurrence of posttraumatic stress disorder symptoms when transitioning to a nursing home. We present the case of an 86-year-old male Holocaust survivor admitted to a nursing home for physical therapy and rehabilitation 6 weeks after the death of his wife; the patient was expressing a persistent death wish. Despite the multiple risk factors for depression, his distress was specifically related to the reemergence of nightly posttraumatic nightmares. Over the course of 1 week of treatment with 1 mg prazosin at bedtime, his nightmares and his death wish completely resolved. He achieved his rehabilitation goals and was discharged to a community setting. This report highlights the importance of considering posttraumatic stress disorder in nursing home residents with a history of emotional trauma, and understanding how to address these symptoms pharmacologically and nonpharmacologically.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23141208     DOI: 10.1016/j.jamda.2012.10.007

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  3 in total

Review 1.  Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013.

Authors:  Scott H Waltman; David Shearer; Bret A Moore
Journal:  Curr Psychiatry Rep       Date:  2018-10-11       Impact factor: 5.285

2.  Spontaneous reporting of onset of disturbing dreams and nightmares related to early life traumatic experiences during the COVID-19 pandemic by patients with posttraumatic stress disorder in remission.

Authors:  Madhulika A Gupta
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

Review 3.  Suicidality in sleep disorders: prevalence, impact, and management strategies.

Authors:  Christopher W Drapeau; Michael R Nadorff
Journal:  Nat Sci Sleep       Date:  2017-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.